1. United Kingdom Stocks

  2. •

    Technology

  3. •

    Software - Application
GenIP plc

GenIP plc

GNIP.L
GenIP plcGB flagLondon Stock Exchange
4.55
GBp
-0.10
- -
816,472.00Market Cap
GenIP plc
GNIP.L
(London Stock Exchange)

Recent

price

4.55

P/E

ratio

- -

div

yld

- -

ROIC.AI

2024
2025
FRC
0.01
- -
Revenue per Share
-0.05
- -
Basic EPS, GAAP
-0.04
- -
Free Cash Flow per Basic Share
- -
- -
Dividend per Share
-0.04
- -
Book Value per Share
0.06
- -
Tangible Book Value per Share
18
- -
Basic Weighted Avg Shares
- -
1
Sales/Revenue/Turnover
-674.34
-250.32
Operating Margin (%)
- -
- -
Depreciation Expense
-1
-1
Net Income, GAAP
- -
- -
Effective Tax Rate (%)
-720.91
-240.41
Profit Margin (%)
1
- -
Working Capital
- -
- -
LT Debt
1
1
Total Equity
- -
- -
Return on Invested Capital (%)
- -
- -
Return on Capital (%)
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-54.47%
Free Cash Flow
- -
- -
7.75%
Net Income, GAAP
- -
- -
41.07%
Sales/Revenue/Turnover
- -
- -
323.03%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
1

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.01
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.05
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Tobila Systems Inc. (4441.T)
Imprivata, Inc. (IMPR)
Ladybug Resource Group, Inc. (LBRG)
Avai Bio, Inc. (AVAI)
Oxford Metrics plc (OMG.L)
TIE Kinetix N.V. (TIE.AS)
Business
GenIP plc (GNIP.L) provides generative artificial intelligence analytic services to help companies, research institutions and venture funds assess and commercialise new technological discoveries. The company combines expert human technical review with proprietary GenAI algorithms to deliver verified insights through two complementary platform-based offerings: Invention Intelligence product suite, including Invention Evaluator for bespoke research reports assessing market potential of innovations, Invention Validator for premium market readiness testing with end-user validation at fees exceeding $12,000, Invention Prioritizer for portfolio-level assessments, and Competitive Intelligence Reports; and Vortechs, an executive recruitment platform using machine learning and natural language processing to match technology organisations with leaders experienced in commercialisation. GenIP serves large corporations, universities, government agencies, medical research institutions and venture funds across 25 countries on six continents, with headquarters in the United Kingdom. Founded prior to its AIM listing in 2024, the company has delivered over 5,800 reports to more than 300 clients worldwide. Recent developments include a December 2025 placing raising 300,000 pounds to fund platform automation integrating high-value products for margin growth and sales expansion in Asia and Latin America; launch of Invention Validator in October 2025 with first sale to a South African university; strategic partnerships such as with Brazil's technology park, new venture studio, and Chile's GreenTech Platform where GenIP serves as designated technology transfer supplier, plus 360 Social Impact Studios; major contract wins comprising a $350,000 Saudi Arabian deal for 400 assessments and a $65,000 Singapore contract; and international expansion with recurring university relationships validating product demand.